Coronavirus Vaccine Research at Valneva SA Labs

A lab technician wearing a full body protection suit handles a bottle containing growth media for virus production during coronavirus vaccine research at the Valneva SA laboratories in Vienna, Austria, on Thursday, Aug. 6, 2020. The U.K. has signed agreements to buy 90 million doses of vaccines in development by drugmakers including Pfizer Inc., BioNTech SE and Valneva SE, joining countries around the world racing to secure supplies of protection against Covid-19. Photographer: Akos Stiller/Bloomberg via Getty Images
A lab technician wearing a full body protection suit handles a bottle containing growth media for virus production during coronavirus vaccine research at the Valneva SA laboratories in Vienna, Austria, on Thursday, Aug. 6, 2020. The U.K. has signed agreements to buy 90 million doses of vaccines in development by drugmakers including Pfizer Inc., BioNTech SE and Valneva SE, joining countries around the world racing to secure supplies of protection against Covid-19. Photographer: Akos Stiller/Bloomberg via Getty Images
Coronavirus Vaccine Research at Valneva SA Labs
COMPRAR LICENCIA
¿Cómo puedo usar esta imagen?
AR$ 329.200,00
ARS

DETALLES

Restricciones:
Póngase en contacto con su oficina local para conocer todos los usos con fines comerciales o promocionales.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Crédito:
Bloomberg / Colaborador
Editorial n.º:
1227935166
Colección:
Bloomberg
Fecha de creación:
06 de agosto de 2020
Fecha de subida:
Tipo de licencia:
Inf. de autorización:
No se cuenta con autorizaciones. Más información
Fuente:
Bloomberg
Nombre del objeto:
AUSTRIA VALNEVA
Tamaño máx. archivo:
4000 x 2667 px (33,87 x 22,58 cm) - 300 dpi - 5 MB